Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
May, J.M.; Hickey, M.; Triantis, I.; Palazidou, E.; Kyriacou, P. A. (2014)
Publisher: IEEE
Languages: English
Types: Article
Subjects: RC, TA
Lithium medication is the gold standard of treatment in Bipolar Disorder patients, preventing and reducing mood swings and suicidality. However, despite its effectiveness, it is a potentially hazardous drug requiring regular monitoring of blood levels to ensure toxic levels are not reached. This paper describes the first steps towards developing a new portable device that can be used by Bipolar Disorder patients to facilitate the analysis of lithium blood levels at home. Solutions of lithium carbonate have been optically fingerprinted using a high-end spectrophotometer. Preliminary measurements indicate that while the visible to near infrared region of the absorption spectra fall heavily within the water band, measurements in the Ultraviolet region show a strong distinction between different lithium concentrations. The optical spectra of Lithium in the 220 nm to 230 nm region demonstrated the ability to differentiate between concentrations representing those found in patients.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • [1] A.L. Price, and G.R. Marzani-Nissen, “Bipolar disorders: a review”, Am Fam Physician, vol. 85, no.5, pp. 483-93, Mar. 2012.
    • [2] Bipolar Disorder, Bipolar Foundation 2012, http://www.bipolarfoundation.org/bipolar-disorder/ (Accessed: 3 Feb 2014).
    • [3] R. Das Gupta, and J.F. Guest, “Annual cost of bipolar disorder to UK society', Br J Psychiatry, vol. 180, pp. 227-233, Mar. 2002.
    • [4] U. Werneke, M. Ott, E.S. Renberg, D. Taylor, and B. Stegmayr, “ A decision analysis of long-term lithium treatment and the risk of renal failure”, Acta Psychiatr Scand, vol. 126, no. (3), pp. 186-97, Sep. 2012.
    • [5] N.J. Delva and E.R. Hawken, “Preventing lithium intoxication. Guide for physicians”, Can Fam Physician, vol. 47, pp. 1595-600, Aug. 2001.
    • [6] J.L. Oliveira, G.B. Silva Júnior, K.L Abreu, N.A. Rocha, L.F. Franco, S.M. Araújo, and E.F. Daher, “Lithium nephrotoxicity”, Rev Assoc Med Bras, vol. 56, no. 5, pp. 600-6, Sep-Oct. 2010.
    • [7] M. Gitlin, and M.A. Frye, “Maintenance therapies in bipolar disorders”, Bipolar Disord, vol. 14, suppl. 2, pp. 51-65, May. 2012.
    • [8] E. Giuliani, D. Iseppi, M.C. Orlandi, A. Alfonso, and A. Barbieri, “Prolonged neurological burden in severe lithium intoxication” Minerva Anestesiol, vol. 76, no. 6, pp. 463-5, Jun. 2010.
    • [9] M. Sampson, M. Ruddel, and R.J. Elin, “Lithium determinations evaluated in eight analyzers”, Clin Chem, vol. 40, no. 6, pp. 869-72, Jun. 1994.
    • [10] National Institute for Health and Care Excellence (NICE), “Bipolar disorder: the management of bipolar disorder in adults,children and adolescents, in primary and secondary care”, no. CG38, 2006.
  • No related research data.
  • No similar publications.

Share - Bookmark

Download from

Cite this article